Business

HEALWELL AI Delivers Record Revenue and First Year of Positive Adjusted EBITDA as Global AI Platform Strategy Takes Hold

Record revenue growth - HEALWELL achieved record annual revenue from continuing operations of ap...

articleHealwell Ai Inc. Class AMarch 19, 20264/company/healwell-ai-inc/news/healwell-ai-delivers-record-revenue-and-first-year-of-positive-adjusted-ebitda-as-global-ai-platform-strategy-takes-hold
HEALWELL AI Delivers Record Revenue and First Year of Positive Adjusted EBITDA as Global AI Platform Strategy Takes Hold

About this update from Healwell Ai Inc. Class A

[{"type":"text","content":"HEALWELL AI Delivers Record Revenue and First Year of Positive Adjusted EBITDA as Global AI Platform Strategy Takes HoldRecord revenue growth - HEALWELL achieved record annual revenue from continuing operations of approximately $103.8 million in fiscal 2025, an increase of 427% compared to the $19.7 million in fiscal 2024. The Company reported an IFRS net loss from continuing operations of $39.1 million in fiscal 2025, compared to a net loss of $24 million in fiscal 2024.First full year of positive Adjusted EBITDA - HEALWELL delivered Adjusted EBITDA of $2.3 million in fiscal 2025 compared to an Adjusted EBITDA loss of $14.2 million in 2024.Transition to a pure-play AI and Software Company - During Q4-2025, HEALWELL completed a series of strategic divestments to transition into a pure-play AI and software company, generating approximately $9.7 million in cash proceeds in this process.Improving balance sheet - HEALWELL ended 2025 with $18.6 million in cash and holds strategic investments that the Company is evaluating to monetize, including a dedicated investment vehicle with an interest in xAI, now part of the broader SpaceX ecosystem.Toronto, Ontario--(Newsfile Corp. - March 19, 2026) - HEALWELL AI Inc. (TSX: AIDX) (OTCQX: HWAIF) (\"HEALWELL\" or the \"Company\"), a healthcare artificial intelligence company focused on preventative care, is pleased to announce its audited consolidated financial results for the fiscal year and fourth quarter ended December 31, 2025. A summary of the Company's financial and operational results is set out below, and more detailed information is contained in the annual financial statements and related management discussion and analysis, which are available on the Company's SEDAR+ page at www.sedarplus.ca. Financial measures described as \"Adjusted\" or \"EBITDA\" in this news release are non-IFRS financial measures and may not be comparable to other similar measures disclosed by other companies. Please see Non-IFRS Financial Measures below for more information.James Lee, Chief Executive Officer of HEALWELL, commented, \"Healthcare is entering its AI deployment era, and HEALWELL has spent the last two years assembling the rare combination of assets required to lead it; a global enterprise distribution network, one of the most scientifically validated clinical AI platforms in the market, and a consen...

More updates from Healwell Ai Inc. Class A